Floatz logo

HYDROXYETHYL STARCH

Prone Position

Samsung Medical CenterOtherDormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Prone Position cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

HYDROXYETHYL STARCH is also rated in:

Fluid ResponsivenessDormant
D
Indicative ·
30 / 100
View asset →
Non Invasive Cardiac Output MonitoringDormant
D
Indicative ·
30 / 100
View asset →
Goal Directed Fluid TherapyDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →